Skip to main content

Table 9 Characteristic of patients with more compromised lung function (FVC < 50% predicted and/or DLCO < 35% predicted). Pre-test diagnosis was represented by NSIP (6 cases, 19%), IPF (6 cases, 19%), sarcoidosis (4 cases, 13%), diffuse neoplastic disease (4 cases, 13%), HP (3 cases, 10%), other (8 cases, 26%)

From: Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients

Patients characteristics (tot 31)

No. (% or SD)

Median age (SD), y

64 (7.8)

Male, No. (%)

22 (70.9)

Pathological diagnosis, No. (%)a

25 (80.6)

Multidisciplinary diagnosis, No. (%) b

26 (83.9)

Pneumothorax, No. (%)

6 (19.4)

Drained Pneumothorax (among those with pneumothorax), No. (%)

5 (83.3)

Mild bleeding, No. (%)

2 (6.4)

Moderate bleeding, No. (%)

4 (12.9)

Severe bleeding, No. (%)

0

Other adverse events, No. (%)

1 (3.2) c

2.4 mm probe, No. (%)

26 (83.9)

2 different sites, No. (%)

9 (29.0)

Number of samples (SD), No.

2.3 (1.0)

  1. aPathological diagnoses were UIP (13 cases, 42%), sarcoidosis (3 cases, 10%), adenocarcinoma (2 cases, 6%), HP (2 cases, 6.5%), OP (2 cases, 6.5%), other (3 cases, 10%).
  2. bMultidisciplinary diagnoses were IPF (14 cases, 45%), sarcoidosis (3 cases, 10%), PPFE (2 cases, 6.5%), adenocarcinoma (2 cases, 6.5%), COP (2 cases, 6.5%), other (3 cases, 10%).
  3. cOther adverse event: empyema; no other complications during or after the procedure